![Rosie Higgins](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
Rosie Higgins is the founder of Syntensor Ltd.
She previously worked as a Senior Vice President of Design and Operations at BenevolentAI Ltd.
Posizioni attive di Rosie Higgins
Società | Posizione | Inizio |
---|---|---|
Syntensor Ltd
![]() Syntensor Ltd Miscellaneous Commercial ServicesCommercial Services Syntensor Ltd is a British company that develops machine learning methods combined with first-principles thinking in biology to assist drug developers, clinicians, and physicians in answering fundamental questions. The company was founded by Clayton Rabideau and Rosie Higgins, with Clayton Rabideau serving as CEO since incorporation. | Fondatore | - |
Precedenti posizioni note di Rosie Higgins
Società | Posizione | Fine |
---|---|---|
BenevolentAI Ltd.
![]() BenevolentAI Ltd. Packaged SoftwareTechnology Services Part of BenevolentAI SA, BenevolentAI Ltd. develops artificial intelligence applications. The company is based in London, UK. The British company was founded in 2015 by Kenneth Patrick Mulvany, Ivan Griffin, Michael Brennan. BenevolentAI was acquired by Odyssey Acquisition SA on April 22, 2022 for $1,087.33 million. | Direttore operativo | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
BenevolentAI Ltd.
![]() BenevolentAI Ltd. Packaged SoftwareTechnology Services Part of BenevolentAI SA, BenevolentAI Ltd. develops artificial intelligence applications. The company is based in London, UK. The British company was founded in 2015 by Kenneth Patrick Mulvany, Ivan Griffin, Michael Brennan. BenevolentAI was acquired by Odyssey Acquisition SA on April 22, 2022 for $1,087.33 million. | Technology Services |
Syntensor Ltd
![]() Syntensor Ltd Miscellaneous Commercial ServicesCommercial Services Syntensor Ltd is a British company that develops machine learning methods combined with first-principles thinking in biology to assist drug developers, clinicians, and physicians in answering fundamental questions. The company was founded by Clayton Rabideau and Rosie Higgins, with Clayton Rabideau serving as CEO since incorporation. | Commercial Services |
- Borsa valori
- Insiders
- Rosie Higgins